ABSI
Price
$2.57
Change
-$0.05 (-1.91%)
Updated
Jun 30 closing price
Capitalization
326.55M
49 days until earnings call
XFOR
Price
$1.89
Change
+$0.06 (+3.28%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
13.6M
30 days until earnings call
Interact to see
Advertisement

ABSI vs XFOR

Header iconABSI vs XFOR Comparison
Open Charts ABSI vs XFORBanner chart's image
Absci
Price$2.57
Change-$0.05 (-1.91%)
Volume$4.25M
Capitalization326.55M
X4 Pharmaceuticals
Price$1.89
Change+$0.06 (+3.28%)
Volume$1.55K
Capitalization13.6M
ABSI vs XFOR Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. XFOR commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a StrongBuy and XFOR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (ABSI: $2.62 vs. XFOR: $1.83)
Brand notoriety: ABSI and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 248% vs. XFOR: 339%
Market capitalization -- ABSI: $326.55M vs. XFOR: $13.6M
ABSI [@Biotechnology] is valued at $326.55M. XFOR’s [@Biotechnology] market capitalization is $13.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileXFOR’s FA Score has 2 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 2 green, 3 red.
According to our system of comparison, XFOR is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 2 TA indicator(s) are bullish while XFOR’s TA Score has 3 bullish TA indicator(s).

  • ABSI’s TA Score: 2 bullish, 6 bearish.
  • XFOR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, XFOR is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -6.09% price change this week, while XFOR (@Biotechnology) price change was -31.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 19, 2025.

XFOR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($327M) has a higher market cap than XFOR($13.6M). ABSI YTD gains are higher at: -1.908 vs. XFOR (-91.685). XFOR has higher annual earnings (EBITDA): 25.2M vs. ABSI (-93.91M). ABSI has more cash in the bank: 134M vs. XFOR (87M). ABSI has less debt than XFOR: ABSI (8.92M) vs XFOR (78M). XFOR has higher revenues than ABSI: XFOR (31.4M) vs ABSI (4.82M).
ABSIXFORABSI / XFOR
Capitalization327M13.6M2,404%
EBITDA-93.91M25.2M-373%
Gain YTD-1.908-91.6852%
P/E RatioN/A0.90-
Revenue4.82M31.4M15%
Total Cash134M87M154%
Total Debt8.92M78M11%
FUNDAMENTALS RATINGS
XFOR: Fundamental Ratings
XFOR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIXFOR
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RERE3.490.36
+11.50%
ATRenew
APAM44.550.02
+0.04%
Artisan Partners Asset Management
INSM99.49-2.25
-2.21%
Insmed
IPHA1.85-0.06
-3.14%
Innate Pharma SA
PRTG5.54-0.42
-7.05%
Portage Biotech Inc

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-1.91%
RXRX - ABSI
62%
Loosely correlated
+0.70%
CRSP - ABSI
61%
Loosely correlated
+4.15%
BEAM - ABSI
58%
Loosely correlated
+1.25%
ABCL - ABSI
57%
Loosely correlated
-4.99%
IMNM - ABSI
48%
Loosely correlated
+6.04%
More

XFOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with XCUR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then XCUR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
-8.50%
XCUR - XFOR
34%
Loosely correlated
+6.22%
SPHDF - XFOR
34%
Loosely correlated
N/A
CRDF - XFOR
32%
Poorly correlated
-0.32%
ABSI - XFOR
31%
Poorly correlated
-3.32%
IMMP - XFOR
28%
Poorly correlated
+0.61%
More